Translating transplantation tolerance in the clinic: where are we, where do we go?
In: Clinical & Experimental Immunology, Jg. 156 (2009-05-01), Heft 2, S. 185-188
Online
academicJournal
Zugriff:
Research networks dedicated to translation of immune tolerance in the clinic currently support pilot trials aiming at immunosuppression withdrawal in kidney or liver allograft recipients. Although results obtained so far indicate that significant hurdles still need to be overcome before organ transplant recipients can be weaned off drugs safely and routinely, recent advances suggest that immunosuppression minimization on the basis of validated biomarkers might become standard practice in a near future. [ABSTRACT FROM AUTHOR]
Copyright of Clinical & Experimental Immunology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Translating transplantation tolerance in the clinic: where are we, where do we go?
|
---|---|
Autor/in / Beteiligte Person: | Goldman, M. ; Wood, K. |
Link: | |
Zeitschrift: | Clinical & Experimental Immunology, Jg. 156 (2009-05-01), Heft 2, S. 185-188 |
Veröffentlichung: | 2009 |
Medientyp: | academicJournal |
ISSN: | 0009-9104 (print) |
DOI: | 10.1111/j.1365-2249.2009.03887.x |
Schlagwort: |
|
Sonstiges: |
|